Nirogacestat Linked With Improved Functional Status in Patients With Desmoid Tumors
Nirogacestat (Ogsiveo) was associated with significant and clinically meaningful improvements in functional…
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors
SpringWorks Therapeutics, Inc.Application based on Phase 3 DeFi trial in which nirogacestat…
Psychosocial Impact and Pain Management for Desmoid Tumors
This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…
Impact and Quality of Life
This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…
Ayala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors
Ayala PharmaceuticalsREHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE)…
Therapeutic Access and Emerging Treatments
This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…
Strategic Desmoid Tumor Education and Access
This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…
NCCN Guidelines and Treatment Insights for Desmoid Tumors
This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…
Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up
Shares of Immunome, Inc. IMNM were up 36.9% on Feb 6 after…
